Skip Navigation and Go To Content


New antibody shows therapeutic effects in mice with Alzheimer’s disease (UTH))

September 7, 2022

A newly developed agonistic antibody reduced the amyloid pathology in mice with Alzheimer’s disease, signaling its promise as a potential treatment for the disease

Read Full Article

New antibody drug shows promise in mouse study; vaping may increase lung vulnerability to virus

March 25, 2022

The ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV), which was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China, is seen in an illustration released by...

Read on External Site

GSBS faculty member Zhiqiang An, PhD

An earns National Academy of Inventors fellowship

January 3, 2022

Read Full Article

Image of Rong Li

GW Researchers Identify Molecule That Blocks Immune Cells from Killing Breast Tumors

November 3, 2021

Study revealed a new way to infiltrate hard-to-treat cancers, unlocking key to potential treatments.

Read Full Article

Research on antibody-drug conjugates shows promise in fighting breast cancer(IMM)

June 16, 2021

An antibody linked with two different antitumor drugs (dual-drug antibody-drug conjugate) is binding to a cancer cell, exhibiting a synergistic cell-killing effect. (Photo courtesy of Kyoji Tsuchikama, PhD)

Read Full Article

Could a Nasal Spray of Designer Antibodies Help to Beat COVID-19? NIH Director's Blog

June 15, 2021

There are now several monoclonal antibodies, identical copies of a therapeutic antibody produced in large numbers, that are authorized for the treatment of COVID-19.

Read Full Article

Antibody-laden nasal spray could provide COVID protection — and treatment

June 4, 2021

Scientists create a hybrid antibody that can sharply cut the amount of SARS-CoV-2 in the lungs of infected mice.

Read Full Article

New IgM antibodies administered intranasally to fight COVID-19 more potent than commonly used ones

June 3, 2021

Zhiqiang An, PhD, was one of the lead authors of a study that revealed engineered IgM antibodies were more potent than standard ones against COVID-19. (Photo by UTHealth)

Read Full Article

Study finds why some cancer drugs may be ineffective(UTH)

April 1, 2021

Researchers with UTHealth have found a possible explanation for why many cancer drugs that kill tumor cells in mouse models won’t work in human trials.

Read Full Article

New antibody therapies found to potentially fight COVID-19(UTH)

January 21, 2021

Researchers have discovered a potential new antibody therapy for COVID-19. (Photo by UTHealth)

Read Full Article

UTSW Study Links Alzheimer's-Related Protein To Diabetes And Obesity

January 20, 2020

A new study found a protein linked to Alzheimer’s Disease also contributes to problems with diabetes and obesity.

Read Full Article

College of Agriculture, Food and Environment inducts latest class of distinguished alumni

January 10, 2020

The University of Kentucky College of Agriculture, Food and Environment today inducted four new members into its Hall of Distinguished Alumni.

Read Full Article

Lessons Learned A year Into A Pandemic

October 23, 2019

The Food and Drug Administration approved a record-breaking 59 new drugs and biologics in 2018 – nearly double its average of 33 new drugs per year.

Read Full Article

CPRIT awards $11 million to UTHealth for cancer research, prevention(UTH)

September 12, 2019

Five innovative cancer-fighting projects at The University of Texas Health Science Center at Houston (UTHealth) received just over $11 million during the latest round of grants awarded by the Cancer Prevention and Research Institute of Texas (CPRIT).

Read Full Article

Study suggests antibody might be a new tool to fight obesity

September 5, 2019

The hormone leptin is produced by fat cells and increases with obesity, leading to high levels of leptin in the blood.

Read Full Article

Researchers find potential new way to target lethal form of leukemia

October 23, 2018

Each year in the U.S., about 20,000 new cases of AML are diagnosed and more than 10,000 people die of the disease.

Read Full Article

TopAlliance and UTHealth Sign a Patent and Technology License Agreement

October 10, 2018

Read Full Article

Antibody Therapeutics Hinder Immune Evasion

August 27, 2017

Proteases in Some Cancer Cells Have the Ability to Break Antibodies by Taking Them Off Their Hinges

Read Full Article

UT Health San Antonio, UT Health Houston Grant Licenses For Biologic Therapeutics

June 27, 2017

Exclusive global license agreements are most financially significant for UT Health San Antonio, with initial $4.5M payment plus royalties.

Read Full Article

1825 Pressler Sarofim Research Building
Houston, TX 77030-3998 United States